|
Tuesday, March 9 — 8:00 AM — Room 2, 3
Click on the numbers in parentheses to display abstracts.
Section F - PULMONARY PATHOLOGY
Chaired by: Aliya Husain and Abida Haque
| 8:00 |
The Impact of Chest Imaging on the Pathologic Diagnosis of Pulmonary, Mediastinal, and Pleural Disease
(1458)
H Xu, TJ Franks, JR Galvin, WD Travis - Armed Forces Institute of Pathology, Washington, DC
|
| 8:15 |
Long Term Survival in Primary Pulmonary Lymphangiectasia
(1418)
WK Funkhouser, CR Esther, LA Fordham, SJ Maygarden, PM Barker - University of North Carolina, Chapel Hill, NC
|
| 8:30 |
CD25+ Lymphocytes Are Expressed in Chronic Pulmonary Allograft Rejection
(1431)
AC Laga, AH Cermik, TC Allen, RJ Barrios, A Haque, DS Zander, R Bag, G Ayala, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Houston, TX
|
| 8:45 |
Expression of C-Kit and Activated C-Kit (Phospho C-Kit) in Thymic Carcinomas and WHO Type B3 Thymomas
(1421)
PB Illei, A Zamo, F Sen, G Inghirami, D Klimstra, R Chairle, G Palestro, M Chilosi - NYU School of Medicine, New York, NY; University of Torino, Torino, Italy; Memorial Sloan-Kettering Cancer Center, New York, NY; University of Verona, Verona, Italy
|
| 9:00 |
Immunohistochemical Detection of p53 and HHV-8 in Usual Interstitial Pneumonia (UIP): A Multi-Center Study of 66 Cases
(1438)
N Mejia, AC Laga, A Haque, SD Hudnall, TC Allen, AC Cermik, R Barrios, DS Zander, PT Cagle - Baylor College of Medicine, Houston, TX; University of Texas-Houston Medical School, Houston, TX; University of Texas Medical Branch, Galveston, TX
|
| 9:15 |
Bone Marrow-Derived Stem Cell Repopulation Contributes Minimally to the Type II Pneumocyte Pool in Transplanted and Native Lungs
(1459)
DS Zander, MA Baz, M Jorgensen, GA Visner, ND Theise, JM Crawford - University of Texas-Houston Medical School, Houston, TX; University of Florida College of Medicine, Gainesville, FL; Beth Israel Medical Center, New York, NY
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
| 11:00 |
Localized Malignant Mesothelioma (LMM): Clinicopathologic Review of 22 Cases
(1396)
TC Allen, A Churg, TV Colby, PT Cagle, AR Gibbs, SP Hammar, J Corson, M Grimes, N Ordonez, VL Roggli, WD Travis, MR Wick - Baylor College of Medicine, Houston, TX; The United States-Canadian Mesothelioma Reference Panel
|
| 11:15 |
Molecular Pathology Analysis of Mesothelial Cell Hyperplasia and Mesothelioma Assists Diagnosis
(1439)
D Mohan, SD Finkelstein, R Pal, L Niehouse, PA Swalsky, SA Yousem - University of Pittsburgh Medical Center
(UPMC), Pittsburgh, PA
|
| 11:30 |
Correlations of Global Gene Expression Profiles with Histology and p16/CDKN2A Deletion Status in 101 Pleural Mesotheliomas
(1434)
F Lopez-Rios, PB Illei, AB Olshen, V Rusch, MF Zakowski, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY
|
| 11:45 |
Her-2/neu Gene Amplification is Uncommon in Human Malignant Mesotheliomas: A Chromogenic In Situ Hybridization Assay (CISH) Using Tissue Microarrays
(1457)
MA Vasef, K Sheibani - University of Iowa, Iowa City, IA; University of Southern California, Los Angeles, California, and Western Medical Center, Santa Ana, CA
|
|
|
